Research and Markets: Global House Dust Mite Allergy Pipeline Review Report 2014

Research and Markets (http://www.researchandmarkets.com/research/tr4q3w/house_dust_mite) has announced the addition of the "House Dust Mite Allergy - Pipeline Review, H1 2014" report to their offering.

This report provides comprehensive information on the therapeutic development for House Dust Mite Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for House Dust Mite Allergy and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

• The report provides a snapshot of the global therapeutic landscape of House Dust Mite Allergy
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for House Dust Mite Allergy and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
• A review of the House Dust Mite Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• A detailed assessment of monotherapy and combination therapy pipeline projects
• Coverage of the House Dust Mite Allergy pipeline on the basis of target, MoA, route of administration and molecule type
• Latest news and deals relating related to pipeline products

House Dust Mite Allergy - Companies Involved in Therapeutics Development

• ALK-Abello A/S
• DBV Technologies
• Stallergenes S.A.
• Circassia Ltd
• Genetic Immunity, Inc
• Anergis SA
• Biomay AG
• Polyrizon Ltd.
  

Drug Profiles

• Allergenic pollen extract of timothy
• MK-8237
• S-524101
• House Dust Mite-SPIRE
• DermAll-HDM
• House Dust Mite Allergen Peptide Carrier Fusion Vaccine
• AllerDM
• Viaskin House Dust Mite
• Recombinant Protein for House Dust Mite Allergy
• PL-103

For more information visit http://www.researchandmarkets.com/research/tr4q3w/house_dust_mite